QB
Qlaris Bio, Inc.
SEC filingBiotechnology · Dedham, MA
Amount raised$3.9Msold at filing
Total offering$3.9M
Investors in the raise8count reported to the SEC
FiledJun 17, 2026first sale Jun 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Barbara M. WirostkoExecutive Officer
Adrienne GravesDirector
Wende M. HuttonDirector
Robert M. WarnerDirector
Frederic GuerardExecutive Officer, Director
Ronald M. HuntDirector
Andrew DanielsonDirector
Executive officers, directors and promoters as listed on the Form D.